Germany’s CureVac said Wednesday that final trial results showed its coronavirus vaccine had an efficacy rate of just 48 percent, far lower than those developed by mRNA rivals BioNTech/Pfizer and Moderna. The outcome had been expected after poor interim data…
Read More
Germany’s Curevac says Novartis to help make COVID jabs
German group Curevac said Thursday it has signed a deal with Novartis for the Swiss pharmaceutical giant to help in its production of the COVID-19 vaccine it is developing. The Swiss giant will make up to 50 million doses of…
Read More
Germany’s Merkel points to variant risk as infections drop
Germany is seeing a promising decline in new coronavirus infections, but must take “very seriously” the risk posed by a more contagious variant and will have to be cautious whenever it starts easing its lockdown, Chancellor Angela Merkel said Thursday….
Read More